Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Up 198.9% in December

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 109,400 shares, a growth of 198.9% from the November 30th total of 36,600 shares. Approximately 9.2% of the company’s stock are short sold. Based on an average daily volume of 534,900 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analysts Forecast Growth

Separately, LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price objective on the stock.

Autonomix Medical Stock Down 5.4 %

Shares of NASDAQ:AMIX traded down $0.19 during midday trading on Friday, hitting $3.30. 41,308 shares of the stock were exchanged, compared to its average volume of 218,191. The company has a market capitalization of $3.80 million and a PE ratio of -0.21. The business’s fifty day simple moving average is $7.67 and its two-hundred day simple moving average is $13.46. Autonomix Medical has a 52-week low of $2.88 and a 52-week high of $152.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.